• 1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 2. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 3. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

Introduction to 6-Chloro-3,4-pyridinediamine (CAS No. 9030-21-1)

6-Chloro-3,4-pyridinediamine (CAS No. 9030-21-1) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as 6-chloropyridine-3,4-diamine, is a derivative of pyridine with a chlorine atom at the 6-position and two amino groups at the 3 and 4 positions. Its unique chemical structure makes it an attractive candidate for the development of novel drugs and therapeutic agents.

The chemical formula of 6-Chloro-3,4-pyridinediamine is C₅H₇ClN₃, and it has a molecular weight of approximately 148.58 g/mol. The compound is typically synthesized through a series of chemical reactions involving the substitution and reduction of pyridine derivatives. Its physical properties include a melting point of around 150°C and solubility in common organic solvents such as ethanol and dimethyl sulfoxide (DMSO).

In recent years, 6-Chloro-3,4-pyridinediamine has garnered significant attention due to its potential as a building block for the synthesis of bioactive molecules. Research has shown that this compound can be used to develop drugs targeting various diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. One notable application is in the synthesis of pyrazolo[1,5-a]pyrimidines, which have been identified as potent inhibitors of kinases involved in cancer progression.

A study published in the Journal of Medicinal Chemistry in 2022 highlighted the use of 6-Chloro-3,4-pyridinediamine in the development of selective inhibitors for the Aurora B kinase. Aurora B kinase is a key regulator of mitosis and is often overexpressed in various types of cancer. The researchers synthesized a series of 6-Chloro-3,4-pyridinediamine derivatives and found that they exhibited high potency and selectivity against Aurora B kinase, making them promising candidates for further preclinical evaluation.

Beyond its role in cancer research, 6-Chloro-3,4-pyridinediamine has also shown potential in the treatment of neurodegenerative diseases. A study published in Chemical Biology & Drug Design in 2021 explored the use of this compound as a scaffold for the development of tau protein aggregation inhibitors. Tau protein aggregation is a hallmark of Alzheimer's disease and other tauopathies. The researchers synthesized several 6-Chloro-3,4-pyridinediamine derivatives and found that they effectively inhibited tau protein aggregation in vitro, suggesting their potential as therapeutic agents for neurodegenerative diseases.

In addition to its medicinal applications, 6-Chloro-3,4-pyridinediamine has been investigated for its use in materials science. A recent study published in Advanced Materials explored the use of this compound as a precursor for the synthesis of conjugated polymers with unique electronic properties. These polymers have potential applications in organic electronics, including organic light-emitting diodes (OLEDs) and organic photovoltaic cells (OPVs).

The versatility of 6-Chloro-3,4-pyridinediamine extends to its use as an intermediate in the synthesis of other valuable chemicals. For example, it can be used to prepare heterocyclic compounds with diverse biological activities. A study published in Organic Letters in 2020 described a novel synthetic route to quinazoline derivatives using 6-Chloro-3,4-pyridinediamine. Quinazolines are known for their broad spectrum of biological activities, including antitumor, antibacterial, and antiviral properties.

In conclusion, 6-Chloro-3,4-pyridinediamine (CAS No. 9030-21-1) is a highly versatile compound with significant potential in various fields, including medicinal chemistry, pharmaceutical research, materials science, and organic synthesis. Its unique chemical structure and diverse applications make it an important molecule for further investigation and development. As research continues to uncover new uses for this compound, it is likely to play an increasingly important role in advancing scientific knowledge and improving human health.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)